Vertex Pharmaceuticals Incorporated

MA · United States · Reporting entity ID 100000000184

Total reported 2019–2025

$691.1M

#26 of 2,960 reporting companies — 0.8% of all reported industry payments

$70.0M in general payments across 65,857 records, plus $621.1M in research funding across 7,003 records.

How it breaks down

General payments $69,998,865

Research funding $621,084,483

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.